Elanco divests canine ear treatment in $135-million dealJanuary 6, 2020A major player in the animal health industry has just unloaded its proprietary treatment for canine otitis externa in an all-cash deal, totaling $135 million.
Education Center - SponsoredRethinking Our Approach to Canine OA: Treating synovial inflammationby • Exubrion TherapeuticsIt’s time to reframe arthritis not just as a painful condition, but as a disease of rampant synovial inflammation. In adopting a proactive treatment strategy that is aimed at modulating the inflammatory process, veterinarians can now provide more effective, long-term care.
